The announcement of the lung age it is a motivation to quit smoking?

##plugins.themes.academic_pro.article.sidebar##

Published Sep 25, 2013
Download
pdf
Vol. 91 No. 9 (2013): Issue Sep 2013

##plugins.themes.academic_pro.article.main##

Samia Ben Mdalla
Helmi Ben Saad
Neila Ben Mansour
Besma Rouatbi
Mejda Ben Esseghair
Sonia Mezghani
Sonia Rouatbi

Abstract

Background: Smoking represents an ever-increasing problem of public health in the world, the impact of which is actually rising. The majority of smokers wish to stop smoking one day. This fact is one of the major acts leading to a better health and wellbeing. In the eighties, the lung age was already mentioned by Morris and Temple, a further tool motivating tobacco cessation.
aim: To determine the lung age of a population of workers and to evaluate the impact of its announcement on the smoking behavior.
methods: It is a prospective study realized during a year (November 2010-November 2011) in a wire enterprise LEONI in Sousse (Tunisia), during an intervention program. 35 adult smokers were concerned by our study. A measurement of the breathing function by “Néo6” and a calculation of the lung age were practiced on all smokers.
results: 35 smoking men (mean ± SD age of 36 ± 7 years, 27 and 28 smokers have, respectively, a high socio-economic level and a high schooling level) were included. The number of daily cigarettes consumed was from 5 to 40. The measurement of the smokers’ respiratory function by the “Neo 6” did not show a pulmonary function defect. The lung age was of 45 ±13 years, significantly higher than the chronological age. The evaluation of the announcement of the lung age, realized one year after, showed that 8 among the 35 workers have stopped smoking and 7 smokers have reduced their tobacco consumption.
Conclusion: Communicating the lung age results is an additional tool motivating tobacco cessation.

Keywords:

Lung age; Smoking; Respiratory function; FEV1; FEV6

##plugins.themes.academic_pro.article.details##

References

  1. Epidemiologie du tabagisme. www.santetunisie.rns.tn (visité le 23 juin 2013).
  2. Gilbert LAGRUE Arrêter de fumer? Ed Odile Jacob Mai 2006.
  3. Morris JF, Temple W. Spirometric «lung age» estimation for motivating smoking cessation. Prev Med 1985;14:655-62.
  4. Expertise Collective. Tabac: comprendre la dépendance pour agir, Paris Edition INSERM, 2004.
  5. Galanti MR, Cnattingius S, Granath F et al. Smoking and environmental iodine as risk factors for thyroiditis among parous women. Eur J Epidemiol 2007;22:467-72.
  6. Perriot J. La conduite de l'aide au sevrage tabagique. Rev Mal Resp 2006; 23 (n° supplémentaire).
  7. Parkes G, Greenhalgh T, Gritten M, et al. Effect on smoking quite rate of telling patients their lung age: the step quit randomized controlled trial. BMJ 2008;336: 589-600.
  8. Ben Saad H, Khemis M, Bougmiza I et al. Spirometric profile of narghile smokers. Rev Mal Respir 2011;28:e39-51.
  9. Ben Saad H. The narghile and its effects on health. Part II: the effects of the narghile on health. Rev Pneumol Clin 2010;66:132- 44.
  10. Ben Saad H. The narghile and its effects on health. Part I: the narghile, general description and properties. Rev Pneumol Clin 2009;65:369-75.
  11. Ben Saad H, Tfifha M, Harrabi I et al. Factors influencing pulmonary function in Tunisian women aged 45 years and more. Rev Mal Respir 2006;23:324-38.
  12. Echelle de Sadoul. http://www.cphg.org/fille/aide-BPCO.doc (visité le 23 juin 2013).
  13. Ben Saad H, Ben Attia Saafi R, Rouatbi S et al. Which definition to use when defining airflow obstruction? Rev Mal Respir 2007;24:323-30.
  14. Abdelghani A, Ben Saad H, Ben Hassen I et al. Evaluation of the deficiency and the submaximal exercise capacity in obstructive sleep apnoea patients. Rev Mal Respir 2010;27:266-74.
  15. Frith P, Crockett A, Beilby J et al. Simplified COPD screening: validation of the Piko-6 in primary care. Prim Care Respir J 2011;20:190-8.
  16. Hayot M, Richaud V, Ben Saad H et al. Le VEM6 est utile pour le diagnostic d'obstruction bronchique dans la BPCO. Rev Mal Respir 2005; 22: R36: 1S123.
  17. McClure J, Ludman E, Grothaus L et al. Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: a comparison of smokers with and without lung impairment. Patient Educ Couns 2010;80:280-3
  18. Kotz, D, Wesseling G, Aveyard P et al. Smoking cessation and development of respiratory health in smokers screened with normal spirometry. Respir Med 2010;105:243-9.
  19. Brelling LP, Rathenba C, Stegnaier C et al. Older smoker's motivation and attempts to quit smoking. Dtsch Arztebl Int 2009;106, 451-5.
  20. Canadian action network for the advancement. Dissemination and adoption of practice-informed tobacco Treatment. Dynamic guidelnes for tabacco control in canadian version 1.0 (guide de pratique sous forme de Wiki). 2008
  21. Centre canadian de lutte contre l'alcoolisme et les toxicomanies. The costs of substance abuse in Canada in 2002. 2006
  22. Treating tobacco use and dependence: 2008 update U.S. Public health service clinical practice guideline executive summary.
  23. Smoking in Canada: a statistical snap short of Canadian smokers. Ottawa. http://www.smoke-free-ca/pdf-1/smokingcanada- 2005.pfd. 2005. (visité le 23 juin 2013).
  24. Nabalamber A, Millar WJ. Aller chez le médecin. Health reports 2007;18, 25-39. http://www.statcan.gc.ca/pub/82-003- x/200602/article/docteur-medecin/9569-forpdf (visité le 23 juin 2013).
  25. Ross H, Blecher E, Yan et al. Do cigarette prices motivate smokers to quit? New evidence from the ITC. Addiction 2011;106:609-19.
  26. Vestbo J, Hurd SS, Agusti AG et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.
  27. Guenard H, Rouatbi S. Aspects physiologiques du vieillissement respiratoire. Rev Mal Respir 2002;19:230-40.
  28. Rouatbi S, Ouahchi Y, Ben Salah C et al. Facteurs physiologiques influençant le volume capillaire pulmonaire et la diffusion membranaire. Rev Mal Respir 2006,23:211-8.
  29. Bize R, Burnand B, Mueller Y et al. Biomedical risk assessment as an aid for smoking cessation. Cochrane Database Syst Rev 2009;(2):CD004705
  30. Bohadana A, Nilsson F, Martinet Y. Detecting airflow obstruction in smoking cessation trials. A rationale for routine spirometry. Chest 2005;128:1252-7.
  31. Enright P, Crapo R. Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers. Clin Chest Med 2000;21:645-52.
  32. Ferguson G, Enright P, Buist A et al. Office spirometry for lung health assessment in adults. A consensus statement from the national lung health education program. Chest 2000;117:1146-61.
  33. Kotz D, Huibers MJ, West RJ et al. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? Patient Educ Couns 2009;76:16-24.
  34. Mannino D. Spirometric screening: Does it work? Thorax 2006; 61:834-5.
  35. Wilt T, Niewoehner D, Kim C-B et al. Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD). Evid Rep Technol Assess (Summ) 2005;121:1-7.
  36. Young R, Hopkins R, Smith M et al. Smoking cessation: The potential role of risk assessment tools as motivational triggers. Postgrad Med J 2010;86:26-33.
  37. Mannino DM, Gagnon RC, Petty TL et al. Obstructive lung disease and low lung function in adults in the United States: data from the national health and nutrition examination survey, 1988- 1994. Arch Intern Med 2000;160:1683-9.
  38. Young RP, Hopkins R, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007;30:616-22.
  39. Anthonisen NR, Skeans MA, Wise RA et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-9.